UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease

European journal of nuclear medicine and molecular imaging, 2022-03, Vol.49 (4), p.1263-1274

2022

Link zum Volltext

Verfügbarkeit prüfen

Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2834-2845

2021

Link zum Volltext

Verfügbarkeit prüfen

A peculiar case of internal carotid dissection: “do not forget Eagle’s syndrome!”

Neurological sciences, 2021-06, Vol.42 (6), p.2527-2529

2021

Link zum Volltext

Verfügbarkeit prüfen

Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease

Neurological sciences, 2022-04, Vol.43 (4), p.2531-2536

2022

Link zum Volltext

Verfügbarkeit prüfen

Brain atrophy in idiopathic REM sleep behaviour disorder is a sign of incipient synucleinopathy

Brain (London, England : 1878), 2022-09, Vol.145 (9), p.2949-2951

2022

Link zum Volltext

Verfügbarkeit prüfen

Electric Source Imaging in Presurgical Evaluation of Epilepsy: An Inter-Analyser Agreement Study

Diagnostics (Basel), 2022-09, Vol.12 (10), p.2303

2022

Link zum Volltext

Verfügbarkeit prüfen

The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer's Disease and Frontotemporal Dementia

Biomedicines, 2022-02, Vol.10 (3), p.544

2022

Link zum Volltext

Verfügbarkeit prüfen

Incident anti-LGI1 autoimmune encephalitis during dementia with Lewy bodies: when Occam razor is a double-edged sword

Journal of neuroimmunology, 2024-02, Vol.387, p.578291-578291, Article 578291

2024

Link zum Volltext

Verfügbarkeit prüfen

Dopaminergic and Serotonergic Degeneration and Cortical [18F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease

Movement disorders, 2021-10, Vol.36 (10), p.2293-2302

2021

Link zum Volltext

Verfügbarkeit prüfen

Stratification Tools for Disease‐Modifying Trials in Prodromal Synucleinopathy

Movement disorders, 2022-01, Vol.37 (1), p.52-61

2022

Link zum Volltext

Verfügbarkeit prüfen

Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)

European journal of nuclear medicine and molecular imaging, 2023-03, Vol.50 (4), p.1090-1102

2023

Link zum Volltext

Verfügbarkeit prüfen

Monoaminergic Disfunctions and Misfolded Proteins levels in the Alzheimer’s Disease Continuum

Alzheimer's & dementia, 2023-12, Vol.19 (S16), p.n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Right posterior hypometabolism in Pisa syndrome of Parkinson’s disease: A key to explain body schema perception deficit?

Parkinsonism & related disorders, 2023-05, Vol.110, p.105371-105371, Article 105371

2023

Link zum Volltext

Verfügbarkeit prüfen

Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages

Cortex, 2024-02, Vol.171, p.413-422

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase and amplitude electroencephalography correlations change with disease progression in people with idiopathic rapid eye-movement sleep behavior disorder

Sleep (New York, N.Y.), 2022-01, Vol.45 (1), p.1

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase and amplitude correlations change with disease progression in idiopathic rapid eye-movement sleep behavior disorder patients

Journal of the neurological sciences, 2021-10, Vol.429, p.118659, Article 118659

2021

Link zum Volltext

Verfügbarkeit prüfen

Paraneoplastic limbic encephalitis with anti-MA2 antibodies: The value of early diagnosis and immunomodulatory treatment

Journal of the neurological sciences, 2021-10, Vol.429, p.117837, Article 117837

2021

Link zum Volltext

Verfügbarkeit prüfen

Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study

Journal of Alzheimer's disease, 2020-01, Vol.74 (3), p.865

2020

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease

Journal of neurology, 2024-04, Vol.271 (4), p.1999-2009

2024

Link zum Volltext

Verfügbarkeit prüfen

Rapid eye movement sleep behavior disorder: A proof‐of‐concept neuroprotection study for prodromal synucleinopathies

European journal of neurology, 2021-04, Vol.28 (4), p.1210-1217

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical and dopaminergic imaging characteristics of the FARPRESTO cohort of trial‐ready idiopathic rapid eye movement sleep behavior patients

European journal of neurology, 2023-12, Vol.30 (12), p.3703-3710

2023

Link zum Volltext

Verfügbarkeit prüfen

Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory

Epileptic disorders, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychological and brain metabolism characteristics of mild cognitive impairment in prodromal Alzheimer's disease and in prodromal synucleinopathy

Journal of the neurological sciences, 2021-10, Vol.429, p.117852, Article 117852

2021

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of FDG-PET at the individual level in MCI-LB versus MCI-AD: A stepwise approach from visual to semi-quantitative analysis

Journal of the neurological sciences, 2021-10, Vol.429, p.117830, Article 117830

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease

Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients

A peculiar case of internal carotid dissection: “do not forget Eagle’s syndrome!”

Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease

Brain atrophy in idiopathic REM sleep behaviour disorder is a sign of incipient synucleinopathy

Electric Source Imaging in Presurgical Evaluation of Epilepsy: An Inter-Analyser Agreement Study

The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer's Disease and Frontotemporal Dementia

Incident anti-LGI1 autoimmune encephalitis during dementia with Lewy bodies: when Occam razor is a double-edged sword

Dopaminergic and Serotonergic Degeneration and Cortical [18F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease

Stratification Tools for Disease‐Modifying Trials in Prodromal Synucleinopathy

Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)

Monoaminergic Disfunctions and Misfolded Proteins levels in the Alzheimer’s Disease Continuum

Right posterior hypometabolism in Pisa syndrome of Parkinson’s disease: A key to explain body schema perception deficit?

Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages

Phase and amplitude electroencephalography correlations change with disease progression in people with idiopathic rapid eye-movement sleep behavior disorder

Phase and amplitude correlations change with disease progression in idiopathic rapid eye-movement sleep behavior disorder patients

Paraneoplastic limbic encephalitis with anti-MA2 antibodies: The value of early diagnosis and immunomodulatory treatment

Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study

Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease

Rapid eye movement sleep behavior disorder: A proof‐of‐concept neuroprotection study for prodromal synucleinopathies

Clinical and dopaminergic imaging characteristics of the FARPRESTO cohort of trial‐ready idiopathic rapid eye movement sleep behavior patients

Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory

Neuropsychological and brain metabolism characteristics of mild cognitive impairment in prodromal Alzheimer's disease and in prodromal synucleinopathy

Accuracy of FDG-PET at the individual level in MCI-LB versus MCI-AD: A stepwise approach from visual to semi-quantitative analysis

Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder

Suchergebnisse filtern